REOPERATION ON PROSTHETIC HEART-VALVES - PATIENT-SPECIFIC ESTIMATES OF IN-HOSPITAL EVENTS

被引:79
作者
PIEHLER, JM
BLACKSTONE, EH
BAILEY, KR
SULLIVAN, ME
PLUTH, JR
WEISS, NS
BROOKMEYER, RS
CHANDLER, JG
机构
[1] ST LUKES HOSP,MID AMER HEART INST,DEPT CARDIOVASC DIS,CARDIOVASC SURG SECT,KANSAS CITY,MO 64111
[2] UNIV ALABAMA,MED CTR,DEPT SURG,DIV CARDIOTHORAC SURG,BIRMINGHAM,AL 35294
[3] MAYO CLIN & MAYO FDN,DEPT HLTH SCI RES,ROCHESTER,MN 55905
[4] PROVIDENCE HLTH CARE SYST,CTR OUTCOMES RES & EDUC SISTERS,PORTLAND,OR
[5] MAYO CLIN SCOTTSDALE,DEPT SURG,DIV THORAC & CARDIOVASC SURG,SCOTTSDALE,AZ
[6] UNIV WASHINGTON,DEPT EPIDEMIOL,SEATTLE,WA 98195
[7] JOHNS HOPKINS UNIV,SCH HYG & PUBL HLTH,DEPT BIOSTAT,BALTIMORE,MD 21205
[8] SHILEY HEART VALVE RES CTR,IRVINE,CA
关键词
D O I
10.1016/S0022-5223(95)70418-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Reoperation on prosthetic heart valves is increasingly under consideration for both clinical and prophylactic indications. To determine the correlates of hospital events, including in-hospital mortality, new persisting neurologic deficit, and length of postoperative stay, a three-institution study of 2246 consecutive prosthetic valve reoperations performed on 1984 patients between 1963 and 1992 was undertaken. The combined experience ranged from high-risk patients coming moribund to the operating room to an important number of well individuals undergoing prophylactic reoperations on potentially failing valves. The risk-unadjusted hospital mortality was 10.8%, neurologic deficit at hospital discharge 1.1%, and length of stay 10 days (median). Multivariably determined correlates of outcome included age at reoperation, degree, severity, and acuity of impairment of cardiac function, extensiveness of valvular heart disease, coexisting morbid conditions, number of previous heart operations, and concomitant procedures. The risk-adjusted hospital mortality for the first elective reoperation in a good-risk patient was 1.3% (90% confidence limits 0.3% to 4.4%), neurologic deficit 0.3% (90% confidence limits 0.02% to 1.8%), and length of postoperative stay 7 days (90% confidence limits 4 to 13), emphasizing the wide variance in outcome events. Equations were developed to permit wide application of the results of the study for quantitatively estimating the risk of outcome events based on individual preoperative patient characteristics. These estimates should be useful for informed patient consent, considerations of prophylactic valve replacement, and cost and resource use.
引用
收藏
页码:30 / 48
页数:19
相关论文
共 27 条
[1]  
AGRESTI A, 1990, CATEGORICAL DATA ANA, P210
[2]   BOOTSTRAP INVESTIGATION OF THE STABILITY OF A COX REGRESSION-MODEL [J].
ALTMAN, DG ;
ANDERSEN, PK .
STATISTICS IN MEDICINE, 1989, 8 (07) :771-783
[3]   ISOLATED REPLACEMENT OF A PROSTHESIS OR A BIOPROSTHESIS IN THE MITRAL-VALVE POSITION [J].
ANTUNES, MJ ;
MAGALHAES, MP .
AMERICAN JOURNAL OF CARDIOLOGY, 1987, 59 (04) :346-349
[4]  
BASKERVILLE JC, 1982, TECHNOMETRICS, V24, P9
[5]   SHOULD PATIENTS WITH BJORK-SHILEY VALVES UNDERGO PROPHYLACTIC REPLACEMENT [J].
BIRKMEYER, JD ;
MARRIN, CAS ;
OCONNOR, GT .
LANCET, 1992, 340 (8818) :520-523
[6]  
Blackstone E H, 1992, J Heart Valve Dis, V1, P3
[7]   DEATH AND OTHER TIME-RELATED EVENTS AFTER VALVE-REPLACEMENT [J].
BLACKSTONE, EH ;
KIRKLIN, JW .
CIRCULATION, 1985, 72 (04) :753-767
[8]  
BLACKSTONE EH, 1977, ANN THORAC SURG, V23, P302, DOI 10.1016/S0003-4975(10)64130-6
[9]  
Bortolotti U, 1994, J Heart Valve Dis, V3, P81
[10]  
BOSCH X, 1984, J THORAC CARDIOV SUR, V88, P567